Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Clinical Application for Modification of the 2022 European Leukemianet Genetic Risk Stratification in Pediatric Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 4313.

https://doi.org/10.1182/blood-2024-201637

Published: 2024

Journal Articles

Genetic Evolution from Chronic Myeloproliferative Neoplasms to Acute Myeloid Leukemia: An Analysis of Forty-Six Paired Samples

Hung Chang, Hsiao-Wen Kao, Ming-Chung Kuo, Jin-Hou Wu, Ying-Jung Huang, Ting-Yu Huang, Tung-Huei Lin, Lee-Yung Shih

Blood (2023) 142 (Supplement 1): 3155.

https://doi.org/10.1182/blood-2023-182624

Published: 2023

Journal Articles

Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan

Ming-Chung Kuo, Chien-Chin Lin, Hsuan-Yu Lin, Jyh-Pyng Gau, Ming-Chung Wang, Ming-Chih Chang, Tsung-Chih Chen, Shih-Peng Yeh, Yeu-Chin Chen, Sr., Cih-En Huang, I-Ju Chiang, Chu-Han Chung, Yee-Ming Lee, Fan-Chen Ku, Cheng-Shyong Chang

Blood (2022) 140 (Supplement 1): 9709–9710.

https://doi.org/10.1182/blood-2022-156146

Published: 2022

Journal Articles

Treatment of Ropeginterferon Alpha-2b Achieves Hematologic Remission and Molecular Response in Patients with Hydroxyurea- and/or Anagrelide-Resistant/Intolerant Myeloproliferative Neoplasms

Chih-Cheng Chen, Ming-Chung Kuo, Yi-Jiun Su, Cih-En Huang, Chia-Chen Hsu, Yu-Ying Wu, Ying-Ju Chen, Lee-Yung Shih

Blood (2021) 138 (Supplement 1): 4631.

https://doi.org/10.1182/blood-2021-147746

Published: 2021

Journal Articles

EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia

Blood (2021) 138 (Supplement 1): 610.

https://doi.org/10.1182/blood-2021-152800

Published: 2021

Journal Articles

Genotype-Phenotype Relationships and Therapeutic Targets in Acute Erythroid Leukemia

June Takeda, MD, Kenichi Yoshida, MDPhD, Akinori Yoda, PhD, Lee-Yung Shih, MD, Yasuhito Nannya, MD PhD, Yotaro Ochi, MD, Ayana Kon, MD PhD, Kenichi Chiba, Yuichi Shiraishi, PhD, Yusuke Shiozawa, MD PhD, Tetsuichi Yoshizato, MD PhD, Cassandra M Kerr, MS, Yasunobu Nagata, MD PhD, Toshiyuki Kitano, MD PhD, Akira Hangaishi, MD PhD, Ken Ishiyama, MD PhD, Hisashi Tsurumi, MD PhD, Yasushi Miyazaki, MD PhD, Nobuhiro Hiramoto, MD, Takayuki Ishikawa, MD PhD, Masahiro Marshall Nakagawa, MDPhD, Akifumi Takaori-Kondo, MD PhD, Shigeru Chiba, MD PhD, Hideyuki Nakazawa, MD PhD, Ming-Chung Kuo, MD, Keisuke Kataoka, MD PhD, Ryunosuke Saiki, MD, Hiroko Tanaka, Kensuke Usuki, MD PhD, Shuichi Miyawaki, MD PhD, Satoru Miyano, PhD, Jaroslaw P. Maciejewski, MD PhD, Arnold Ganser, Michael Heuser, Prof., MD, Felicitas Thol, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141750

Published: 2020

Journal Articles

Prognostic Relevance of Genetic Abnormalities in Blastic Transformation of Chronic Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-140629

Published: 2020

Journal Articles

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Hsin-An Hou, Chien-Chin Lin, MD, Ming-Chung Kuo, MD, Shyuann-Yuh Lin, MD, Jyh-Pyng Gau, MD, Ming-Chung Wang, MD, Ming-Chih Chang, MD, Tsung-Chih Chen, MD, Su-Peng Yeh, MD, Yeu-Chin Chen, MD, Cih-En Huang, MD, Chieh-Wen Chen, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Lee-Yung Shih, MD

Blood (2019) 134 (Supplement_1): 5374.

https://doi.org/10.1182/blood-2019-129645

Published: 2019

Journal Articles

Molecular Profiling of Blastic Transformation in Chronic Myeloid Leukemia

Yotaro Ochi, MD, Kenichi Yoshida, MD PhD, Ying-Jung Huang, Ming-Chung Kuo, Yusuke Shiozawa, MD, PhD, Yasuhito Nannya, MD PhD, Yuichi Shiraishi, PhD, Ai Okada, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Akifumi Takaori-Kondo, MD PhD, Lee-Yung Shih, MD, Seishi Ogawa, MD PhD

Blood (2018) 132 (Supplement 1): 1725.

https://doi.org/10.1182/blood-2018-99-114512

Published: 2018

Journal Articles

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Yi-Jiun Su, MD, Ming-Chung Kuo, MD, Chieh-Lin Teng, MD, Tsai-Yun Chen, MD, Ming-Chun Ma, MD, Pei-Ching Hsiao, MD, Ming-Chung Wang, MD, Tung-Huei Lin, MS, Wen-Li Hwang, MD, Chih-Cheng Chen, MD, Youngsen Yang, MD, Sung-Nan Pei, MD, Yen-Min Huang, MD, Sin-Syue Li, MD, Ming-Yang Lee, MD, Hung-I Cheng, MD, Lee-Yung Shih, MD

Blood (2017) 130 (Supplement 1): 1603.

https://doi.org/10.1182/blood.V130.Suppl_1.1603.1603

Published: 2017

Journal Articles

Clinical Features and Morbidities of Hb H Disease in Taiwan

Meng Yao Lu, Ming Chung Kuo, Shih Chung Wang, Shih Hsiang Chen, Bor Sheng Ko, Cheng-Shyong Chang, MD, Jih-Luh Tang, MD PhD

Blood (2016) 128 (22): 4836.

https://doi.org/10.1182/blood.V128.22.4836.4836

Published: 2016

Journal Articles

Clonal Evolution of Gene Mutations in AML Transformation from Patients with De Novo Myelodysplastic Syndromes Carrying Spliceosome Mutations: An Analysis of 71 Paired Samples

Ming-Chung Kuo, MD, Po-Nan Wang, MD, Po Dunn, MD, Tung-Liang Lin, MD, Jin-Hou Wu, MD, Tzung-Chih Tang, MD, Yi-Jung Wu, MS, Tung-Huei Lin, MS, Chia-Hui Chang, BS, Ting-Yu Huang, MS, Che-Wei Ou, MD, Der-Cherng Liang, MD, Lee-Yung Shih, MD

Blood (2016) 128 (22): 1969.

https://doi.org/10.1182/blood.V128.22.1969.1969

Published: 2016

Journal Articles

Clinical Relevance of Molecular Markers in Taiwan Chinese Patients with Primary Myelofibrosis: Endogenous Erythroid Colony Growth Is the Most Important Predictor of Outcomes

Ming-Chung Kuo, MD, Tzung-Chih Tang, MD, Tung-Liang Lin, MD, Po-Nan Wang, MD, Po Dunn, MD, Jin-Hou Wu, MD, Hung Chang, MD, Tung-Huei Lin, MS, Chia-Hui Chang, BS, I-Jung Wu, MS, Lee-Yung Shih, MD

Blood (2015) 126 (23): 4083.

https://doi.org/10.1182/blood.V126.23.4083.4083

Published: 2015

Journal Articles

Sokal Risk Score Is Superior to Hasford and EUTOS in Determining Survival Outcomes for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

Brian Gabriel Jiang, Dong-Wook Kim, MD, Lee-Yung Shih, MD, Charles Chuah, Hein Than, MD, Ming-Chung Kuo, MD, HuiHua Li, PhD, John Carson Allen, Jr., PhD, Lionel KY See, Bernard KC Yap, Yeow-Tee Goh, MBBS, MMed

Blood (2015) 126 (23): 4044.

https://doi.org/10.1182/blood.V126.23.4044.4044

Published: 2015

Journal Articles

Clonal Evolution of Gene Mutations Involving DNA Methylation in the Progression of CMML to Secondary AML

Hsiao-Wen Kao, MD, Ming-Chung Kuo, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD, Tung-Huei Lin, MS, Yu-Shu Shih, MS, Der-Cherng Liang, MD, Lee-Yung Shih, MD

Blood (2015) 126 (23): 4120.

https://doi.org/10.1182/blood.V126.23.4120.4120

Published: 2015

Journal Articles

Profiling of somatic mutations in acute myeloid leukemia with FLT3 -ITD at diagnosis and relapse

Blood (2015) 126 (22): 2491–2501.

https://doi.org/10.1182/blood-2015-05-646240

Published: 2015

Includes: Supplemental data

Journal Articles

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Ming-Chung Kuo, MD, Tsai-Yun Chen, MD, Ming-Chung Wang, MD, Youngsen Yang, MD, Su-Peng Yeh, MD, Cheng-Shyong Chang, MD, Yii-Jenq Lan, MD, Chih-Cheng Chen, MD, Yu-Chieh Su, MD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, MD, Li-Yuan Bai, MD, Wen-Li Hwang, MD, Lee-Yung Shih, MD

Blood (2014) 124 (21): 4544.

https://doi.org/10.1182/blood.V124.21.4544.4544

Published: 2014

Journal Articles

Co-Existing Gene Mutations at Diagnosis and at Relapse in De Novo Acute Myeloid Leukemia with MLL Translocations

Der-Cherng Liang, MD, Lee-Yung Shih, MD, Ming-Chung Kuo, MD, Chao-Ping Yang, MD, Hsi-Che Liu, MD, Tang-Her Jaing, MD, Jen-Fen Fu, PhD, Yu-Shu Shih, MS, Tung-Huei Lin, MS

Blood (2014) 124 (21): 1008.

https://doi.org/10.1182/blood.V124.21.1008.1008

Published: 2014

Journal Articles

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Hsuan-Jen Shih, MD, Lee-Yung Shih, MD, Hung Chang, MD, Ming-Chung Kuo, MD, Tung-Huei Lin, MS, Chen-Yu Lai, MS, Yu-Shu Shih, MS, Yu-Hui Huang, MS, Tung-Liang Lin, MD, Po-Nan Wang, MD, Jin-Hou Wu, MD

Blood (2013) 122 (21): 2786.

https://doi.org/10.1182/blood.V122.21.2786.2786

Published: 2013

Journal Articles

Mutations Of Genes Regulating DNA Methylation Are Common In MLL Partial Tandem Duplication AML and DNMT3A Mutations Are Associated With Adverse Outcome

Hsiao-Wen Kao, MD, Lee-Yung Shih, MD, Ming-Chung Kuo, MD, Tung-Liang Lin, MD, Sung-Tzu Liang, PhD, Chao-Ping Yang, MD, Yu-Shu Shih, MS, Yu-Hui Huang, MS, Tung-Huei Lin, MS, Der-Cherng Liang, MD

Blood (2013) 122 (21): 1407.

https://doi.org/10.1182/blood.V122.21.1407.1407

Published: 2013

NARROW

Clinical Application for Modification of the 2022 European Leukemianet Genetic Risk Stratification in Pediatric Acute Myeloid Leukemia

Genetic Evolution from Chronic Myeloproliferative Neoplasms to Acute Myeloid Leukemia: An Analysis of Forty-Six Paired Samples

Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan

Treatment of Ropeginterferon Alpha-2b Achieves Hematologic Remission and Molecular Response in Patients with Hydroxyurea- and/or Anagrelide-Resistant/Intolerant Myeloproliferative Neoplasms

EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia

Genotype-Phenotype Relationships and Therapeutic Targets in Acute Erythroid Leukemia

Prognostic Relevance of Genetic Abnormalities in Blastic Transformation of Chronic Myeloid Leukemia

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Molecular Profiling of Blastic Transformation in Chronic Myeloid Leukemia

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Clinical Features and Morbidities of Hb H Disease in Taiwan

Clonal Evolution of Gene Mutations in AML Transformation from Patients with De Novo Myelodysplastic Syndromes Carrying Spliceosome Mutations: An Analysis of 71 Paired Samples

Clinical Relevance of Molecular Markers in Taiwan Chinese Patients with Primary Myelofibrosis: Endogenous Erythroid Colony Growth Is the Most Important Predictor of Outcomes

Sokal Risk Score Is Superior to Hasford and EUTOS in Determining Survival Outcomes for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

Clonal Evolution of Gene Mutations Involving DNA Methylation in the Progression of CMML to Secondary AML

Profiling of somatic mutations in acute myeloid leukemia with FLT3 -ITD at diagnosis and relapse

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Co-Existing Gene Mutations at Diagnosis and at Relapse in De Novo Acute Myeloid Leukemia with MLL Translocations

Clonal Leukemic Evolution In Myelodysplastic Syndromes With ASXL1 and EZH2 mutations: A Comparative Analysis Of 58 Paired Samples

Mutations Of Genes Regulating DNA Methylation Are Common In MLL Partial Tandem Duplication AML and DNMT3A Mutations Are Associated With Adverse Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only